GlassScriptPhysician profile
Joseph Thomas Mando
NPI 1477997591
$4,366.77
in general payments reported to CMS, 2019-2025
28 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $297 · 2021: $779 · 2022: $439 · 2023: $562 · 2024: $974 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,328 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,327.63 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,339.40 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Rxsight INC | $860.90 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $689.30 | 2019-2025 | Clareon Panoptix Pro, Centurion, Lensx |
| Ivantis, INC | $191.62 | 2021 | |
| Dompe US, INC. | $169.01 | 2020-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $126.49 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $125.90 | 2024-2025 | Envista Mx60 Iol, Vyzulta, Miebo |
| Carl Zeiss Meditec USA, INC. | $117.00 | 2021 | |
| Biotissue Holdings INC. | $95.74 | 2019-2023 | |
| Abbvie INC. | $94.74 | 2022-2025 | |
| Beaver-Visitec International, INC. | $85.53 | 2023 | |
| Allergan, INC. | $84.72 | 2020-2021 | |
| Sight Sciences, INC. | $72.06 | 2020-2025 | Sion Surgical Instrument, Omni Surgical System |
| Glaukos Corporation | $38.20 | 2022-2024 | Idose |
| Horizon Therapeutics Plc | $36.10 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $27.49 | 2021 | |
| Lombart Brothers, INC. | $27.44 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $21.33 | 2019 | |
| Aerie Pharmaceuticals, INC. | $19.94 | 2020 | |
| Mallinckrodt Enterprises LLC | $19.84 | 2019 | |
| Oyster Point Pharma, INC. | $19.43 | 2022 | |
| Omeros Corporation | $18.42 | 2019 | |
| Thea Pharma INC. | $16.60 | 2024 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.93 | 2019 | |
| Ocular Therapeutix, INC. | $14.61 | 2020 | |
| Halozyme INC | $14.11 | 2019 | |
| Shire North American Group INC | $13.22 | 2019 | |
| Rayner Intraocular Lenses Limited | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.